C-GRIID researchers' findings to help in design of drugs against virus causing childhood illnesses
March 27, 2013
WEST LAFAYETTE, Ind. - New research findings may help scientists design drugs to treat a virus infection that causes potentially fatal brain swelling and paralysis in children. The virus, called enterovirus 71, causes hand, foot and mouth disease
Read Full StoryC-GRIID Scientists Reveal the Crystal Structure of Human Enterovirus 71
March 27, 2012
C-GRIID affiliated researchers have determined the 3.8-angstrom resolution crystal structure of the human enterovirus 71 - an RNA virus member of the picornavirus family that may lead to paralysis and encephalitis in infants and young children. The s
Read Full StoryResearch points to possible new route to fight dengue virus
March 23, 2012
WEST LAFAYETTE, Ind. - Researchers have identified enzymes and biochemical compounds called lipids that are targeted and modified by the dengue virus during infection, suggesting a potential new approach to control the aggressive mosquito-borne patho
Read Full StoryPurdue researchers look to develop new method to control disease-carrying insects
March 23, 2012
WEST LAFAYETTE, Ind. - Purdue researchers are discovering the next generation of insecticides directed at disease-carrying insects like mosquitoes, ticks and tsetse flies, which could help professionals in the human health, veterinary and crop produc
Read Full StoryResearch points to possible new route to fight dengue virus
March 22, 2012
WEST LAFAYETTE, Ind. - Researchers have identified enzymes and biochemical compounds called lipids that are targeted and modified by the dengue virus during infection, suggesting a potential new approach to control the aggressive mosquito-borne patho
Read Full StoryPurdue researchers look to develop new method to control disease-carrying insects
January 30, 2012
C-GRIID affiliated researchers at Purdue, Catherine Hill and Val Watts, have developed a new discovery pipeline to identify the next generation of insecticides directed at disease-carrying insects like mosquitoes, ticks and tsetse flies.
Read Full StoryC-GRIID scientists launch an infectious disease symposium at Tsinghua University
November 30, 2011
Tsinghua University and Purdue University have recently established an agreement for research collaborations in three key areas: renewable energy, nano-medicine, and structural biology/infectious disease. The symposium is intended to promote scientif
Read Full StorySanofi Reiterates Commitment To Fight Against Malaria
November 30, 2011
French drug maker Sanofi SA (SNY) on Tuesday confirmed its decades-long commitment to the fight against malaria, noting that the elimination of the disease has now become an achievable goal.
Read Full StoryNovartis Malaria Medicine Kills Bugs at Earliest Stage, Study Shows
November 30, 2011
Novartis AG (NOVN) developed a new class of experimental malaria drugs, its second in 14 months, advancing the search for treatments to replace current medicines as they lose potency against the infectious killer.
Read Full Story
About C-GRIID
The focus of C-GRIID is the development of comprehensive intervention strategies to control and reduce the incidence and severity of infectious diseases in humans and animals world-wide.
Current Events
No current events were found.
C-GRIID Programs
Contact
Tommy Sors
Center Project Manager
Bindley Bioscience Center
1023 W. State Street
West Lafayette, IN 47907-2057
- tsors@purdue.edu
- Phone: 765.494.1678